Gelteq begins veterinary clinical trial for antiparasitic drug candidate

Go back to Gelteq begins veterinary clinical trial for antiparasitic drug candidate
(NASDAQ: GELS) Delayed: 0.73 -0.14 (16.09%)
Previous Close $0.87    52 Week High
Open $0.84    52 Week Low
Day High $0.84    P/E N/A 
Day Low $0.73    EPS
Volume 159,610